Sarcopenia and malnutrition in relation to mortality in hospitalised patients in geriatric care - predictive validity of updated diagnoses.

Clin Nutr ESPEN

Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden; Theme Inflammation and Ageing, Karolinska University Hospital, Stockholm, Sweden.

Published: October 2021

Background And Aim: The definition of sarcopenia was recently updated by the European Working Group on Sarcopenia (EWGSOP2), and consensus criteria for the diagnosis of malnutrition have been presented by the Global Leadership Initiative on Malnutrition (GLIM). The aim of this study was to investigate prevalence and mortality related to categorisation of patients according to these definitions in a geriatric hospital setting.

Method: Fifty-six consecutive geriatric inpatients (84y (SD 7.3), 68% women) underwent test of handgrip strength (HGS) and five-rise chair stand test (5CST). Muscle mass and fat free mass (FFM) were evaluated by Dual X-ray Absorptiometry (DXA). Calf circumference (CC) was recorded. Probable sarcopenia was defined, according to EWGSOP2, as low HGS (<27/16 kg for men/women) and/or 5CST >15 s; sarcopenia was confirmed when coupled with low appendicular skeletal muscle index (ASMI <7.0 and <5.5 kg/m (m/w)). Malnutrition was defined according to GLIM as weight loss >5% (past 6 mo); BMI <20/22 kg/m (<70/>70y); and FFM-index <17/15 kg/m (m/w) combined with reduced food intake and/or disease burden/inflammatory condition. Alternatively, CC <31 cm was used as a proxy for low muscle mass for both sarcopenia and malnutrition. One- and two-year mortality was registered.

Results: All participants displayed probable sarcopenia; 46% and 20% were sarcopenic depending on whether muscle mass was estimated by DXA or CC. Malnutrition according to the GLIM criteria was prevalent in 64% or 60% (muscle mass by DXA or CC, respectively). Nine in ten with sarcopenia were also malnourished. Twenty-six participants (46%) died within two years. Sarcopenia defined by CC <31 cm, but not by DXA, was associated with increased mortality; e.g. 2-y mortality HR was 3.19 (95% CI 1.31-7.75). Similarly, malnutrition according to GLIM related to increased 1-y mortality (HR 4.83, 95% CI 1.04-22.39) when DXA was used for muscle mass estimation. All of the participants with CC <31 cm were categorised as both sarcopenic and malnourished.

Conclusion: In this small set of well-characterised geriatric inpatients all displayed probable sarcopenia. Prevalence of sarcopenia (EWGSOP2) and malnutrition (GLIM) was 20-46% and 60-64%, respectively. Both conditions related to mortality. CC <31 cm hold promises to be an acceptable alternative for DXA as a proxy for low muscle mass.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clnesp.2021.07.002DOI Listing

Publication Analysis

Top Keywords

sarcopenia
5
sarcopenia malnutrition
4
malnutrition relation
4
relation mortality
4
mortality hospitalised
4
hospitalised patients
4
patients geriatric
4
geriatric care
4
care predictive
4
predictive validity
4

Similar Publications

Introduction: Sarcopenia, characterized by reduced skeletal muscle mass (RMM), is increasingly recognized as a significant factor influencing outcomes in various health conditions, including stroke. Although most studies focus on sarcopenia developing during stroke rehabilitation, the impact of sarcopenia present at the onset of acute ischemic stroke remains underexplored. This study aims to evaluate the effect of RMM at stroke onset on 3-month functional outcomes in acute ischemic stroke patients.

View Article and Find Full Text PDF

Context: Dietary protein is recommended for sarcopenia-a debilitating condition of age-related loss of muscle mass and strength that affects 27% of older adults. The effects of protein on muscle health may depend on protein quality.

Objective: The aim was to synthesize randomized controlled trial (RCT) data comparing plant with animal protein for muscle health.

View Article and Find Full Text PDF

Late-onset Systemic Lupus Erythematosus.

Rheumatol Int

January 2025

Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Kraków, Kraków, Poland.

Systemic lupus erythematosus (SLE) is a multisystem autoimmune rheumatic disease (ARD) that results from the dysregulation of multiple innate and adaptive immune pathways. Late-onset SLE (Lo-SLE) is the term used when the disease is first diagnosed after 50-65 years, though the standard age cut-off remains undefined. Defining "late-onset" as lupus with onset after 50 years is more biologically plausible as this roughly corresponds to the age of menopause.

View Article and Find Full Text PDF

Energy Expenditure in Chronic Kidney Disease: Affecting Factors and Evaluation Methods.

Nutr Rev

January 2025

Faculty of Health Sciences, Department of Nutrition and Dietetics, Gazi University, Ankara 06495, Türkiye.

Chronic kidney disease (CKD) is a chronic health problem whose prevalence is increasing. Nutrition and nutrition-related factors, one of the modifiable risk factors for CKD, are of primary importance. The key to planning optimal nutritional therapy is accurately determining energy requirements and total energy expenditure.

View Article and Find Full Text PDF

From molecular to physical function: The aging trajectory.

Curr Res Physiol

December 2024

Department of Kinesiology, McMaster University, Hamilton, Ontario, Canada.

Aging is accompanied by a decline in muscle mass, strength, and physical function, a condition known as sarcopenia. Muscle disuse attributed to decreased physical activity, hospitalization, or illness (e.g.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!